Category: Approval/Launch Region: Europe · United Kingdom Company: Astrazeneca Ltd

Enhertu approved in the EU for patients with previously treated HER2-positive advanced gastric cancer

Enhertu approved in the EU for patients with previously treated HER2-positive advanced gastric cancer
AstraZeneca and Daiichi Sankyo

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!